IARC opens a searchable portal to its carcinogen evaluations
The International Agency for Research on Cancer has launched IARC-MonDO, a new online database built to make the agency’s monographs easier to search, compare, and use in practice. The platform brings together key information on every agent evaluated across the IARC Monographs on the Identification of Carcinogenic Hazards to Humans programme over its 55-year history.
For scientists, regulators, and public health teams, the practical value is immediate. Instead of moving through individual monographs one by one, users can now search a single database and pull up the overall classification, the evidence for cancer in humans, the evidence from experimental animals, and the mechanistic findings tied to each agent. In a field where prevention decisions often depend on the quality and consistency of hazard evidence, the difference between scattered documents and a structured database is substantial.
What the database contains and how it is organized
IARC-MonDO was designed as a comprehensive and readily searchable tool. Users can look up information on agents evaluated by the monographs programme and filter results by agent class, classification group, cancer type, evidence stream, and other factors. The system also includes information on previous and current evaluations for agents that have been reviewed more than once, while clearly displaying the current classification.
That feature matters because carcinogen assessment is not static. Evidence accumulates, mechanistic understanding deepens, and some agents return for re-evaluation as new data emerge. A single agent may therefore have a history of multiple assessments, and users need a way to distinguish an older judgment from the most current classification without losing sight of the scientific record. IARC-MonDO makes that distinction visible inside the database itself.
One sentence captures the central utility of the platform: it turns a large archive into a searchable prevention tool.
The database also allows users to create charts and visual reports, with customization expected to expand as the platform develops. For institutions building policy briefs, scientific summaries, or teaching materials, that function may shorten the distance between evidence review and communication. Users can also download the list of classifications by cancer type, which should be useful for those assembling cross-agent comparisons or population-level prevention materials.
Why mechanistic evidence matters in cancer prevention
The architecture of IARC-MonDO reflects how carcinogen evaluation actually works. Human evidence remains central, but classification does not rest on epidemiology alone. Experimental animal data and mechanistic evidence are also part of the assessment, including evidence linked to the key characteristics of carcinogens.
That broader framework is essential because cancer hazard identification is not simply a list of exposures and labels. The biology of carcinogenesis often unfolds through DNA damage, altered cell signaling, chronic inflammation, endocrine disruption, immune modulation, or other pathways that may not be fully captured by a single human study. By allowing users to search across evidence streams, the database gives greater visibility to the reasoning behind each classification and to the biological support that underpins prevention policy.
For public health agencies, this structure can sharpen action. A compound with strong mechanistic signals and concordant animal findings may warrant attention even when human data are incomplete, especially if exposure is widespread or avoidable. In prevention science, the aim is not only to document harm after the fact but to identify hazards early enough to reduce exposure before disease burden rises.
A tool built for scientists and public health agencies
IARC says the platform is intended to be regularly optimized and updated, with feedback welcomed as the database matures. That matters because tools like this succeed only if they remain usable for the people who rely on them. A database of carcinogen evaluations must serve both specialist researchers and agencies that need concise, defensible evidence for decision-making.
The launch also fits neatly with the role of the monographs programme itself. IARC describes the programme as an “encyclopaedia of carcinogens,” and the new platform appears designed to make that encyclopaedia less cumbersome to navigate. Rather than searching across monographs individually, users can interrogate the evidence base by agent or by cancer type and retrieve current classifications in a form that is easier to compare across hazards.
For scientists working in cancer prevention, that may translate into faster literature triage, cleaner evidence mapping, and less duplication of effort. For agencies, it may support clearer communication when translating hazard identification into regulation, exposure limits, or education campaigns. The underlying scientific content has not changed; the access path has.
What the launch does not change
IARC-MonDO is a database, not a new round of hazard evaluation. It does not create new classifications, and it does not substitute for the primary monographs themselves. Its value lies in organization, retrieval, and presentation of existing evaluations across a long-running programme.
Even so, access can change practice. A prevention framework is only as useful as the speed and clarity with which decision-makers can move from evidence to action. When the evidence base is buried in separate reports, even strong findings can be slow to enter policy conversations. A searchable system reduces that friction.
The launch leaves a few concrete questions for the next stage of development. How far will the customization tools expand? How often will updates be incorporated? How widely will public health agencies adopt the platform in routine work? Those details will determine whether the database becomes a specialized reference site or a standard working instrument for carcinogen assessment.
For now, IARC-MonDO gives cancer prevention specialists a centralized entry point into one of the most important reference systems in environmental and occupational oncology. The database is open, searchable, and organized around the evidence streams that define carcinogen classification—precisely the kind of infrastructure that can make prevention science easier to use at the bedside of public policy.